Silo Pharma SILO
NASDAQ SILO
$2.65 -0.09 (-3.28%)
As of: Aug 21, 2026 · 3:59 PM EDT

Silo Pharma (SILO) Change in Receivables (2022 - 2023)

Silo Pharma (SILO) posted Change in Receivables of $1210.0 for Q3 2023, up 1.09% sequentially from $1197.0 in Q2 2023, and little changed YoY from $1210.0 in Q3 2022.

Silo Pharma (SILO) Change in Receivables (2022 - 2023) Analysis & Trends

Silo Pharma has reported Change in Receivables for 2 years, with the latest figure at $1210.0 in Q3 2023.

  • Quarterly Change in Receivables changed 0.0% year-over-year to $1210.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $3590.0 (down 25.21% YoY) and the FY2023 annual result came in at $3590.0, down 25.21% from the prior year.
  • Change in Receivables rose to $1210.0 in Q3 2023 per SILO's latest filing, from $1197.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $1210.0 in Q3 2022 and troughed at $1183.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -53.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 117.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 31.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 94.29 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 37.16 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Silo Pharma 2.92 Mn 2.92 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 1,210.00
Sep 30, 2023 1,210.00
Jun 30, 2023 1,197.00
Jun 30, 2023 1,197.00
Mar 31, 2023 1,183.00
Mar 31, 2023 1,183.00
Dec 31, 2022 1,210.00
Dec 31, 2022 1,210.00
Sep 30, 2022 1,210.00
Sep 30, 2022 1,210.00
Jun 30, 2022 1,196.00
Jun 30, 2022 1,196.00
Mar 31, 2022 1,184.00
Mar 31, 2022 1,184.00